How to Afford GLP-1 Medications: Programs, Coupons, and Compounding

The retail price of semaglutide is brutal. Wegovy (the weight-loss version) lists at $1,349/month. Ozempic (the diabetes version, frequently used off-label for weight loss) runs $935/month. For most Americans, that's simply not affordable out of pocket — especially for a medication you may need indefinitely.

But "list price" is almost never what people actually pay. There's a whole ecosystem of savings programs, insurance strategies, and alternatives that can dramatically reduce your cost. Here's the complete guide to how to afford semaglutide in 2026.

Option 1: Manufacturer Savings Programs

Novo Nordisk — the maker of Ozempic and Wegovy — offers savings programs that can dramatically reduce cost for commercially insured patients.

Wegovy Savings Card: Commercially insured patients may pay as little as $0/month for their first month, then $25-$99/month depending on the program tier. Eligibility requires commercial (non-government) insurance. Visit saveoncostglp1.com for current offers.

Ozempic Savings Card: Similar program — eligible commercially insured patients can pay $25/month or less. If you're using Ozempic off-label for weight loss with a valid prescription, you may still qualify.

Important caveats: - These programs are for commercially insured patients only (no Medicare, Medicaid, or government-subsidized plans) - Income limits may apply - Programs can change; always check the manufacturer's current website

Option 2: Insurance Coverage — How to Actually Get It

Getting insurance to cover GLP-1s for weight loss is possible but requires navigating prior authorization requirements.

For Wegovy (weight loss indication): - Most commercial plans require BMI ≥30 OR BMI ≥27 with at least one weight-related condition (hypertension, sleep apnea, type 2 diabetes, dyslipidemia, cardiovascular disease) - Prior authorization is nearly universal — your prescriber must document medical necessity - If denied, appeal. First appeals succeed in 30-40% of cases. Second appeals succeed in additional cases. - Document everything: blood pressure, lipids, A1c, documented weight history, previous diet/exercise attempts

For Ozempic (diabetes indication): - If you have type 2 diabetes or prediabetes, coverage is significantly better — most plans cover Ozempic for diabetes management - Some plans cover it for prediabetes with documentation

Tips for prior authorization success: 1. Have your doctor document BMI and weight-related comorbidities explicitly 2. Include documentation of "failure" with 3-6 months of lifestyle intervention 3. Include fasting glucose, A1c, lipids, and blood pressure — any abnormality strengthens the case 4. Ask your prescriber's office if they have a prior auth specialist — many large practices do

Option 3: Compounded Semaglutide — The Most Affordable Route

During the period of FDA-declared shortage (which has been the status for most of 2023-2025), 503B outsourcing facilities and 503A compounding pharmacies have been legally permitted to compound semaglutide. This has created a parallel market at dramatically lower prices.

Cost comparison: - Brand-name Wegovy (retail): ~$1,349/month - Brand-name Ozempic (retail): ~$935/month - Compounded semaglutide (typical range): $199-$399/month depending on dose and provider

How compounding works: FDA-registered compounding pharmacies source pharmaceutical-grade semaglutide base and compound it into injectable pens or vials at the requested dose. The active ingredient is chemically identical to Ozempic/Wegovy; what differs is the formulation (no inactive ingredient patent protection applies).

What to look for in a compounding provider: - 503B outsourcing facility registration (higher standards than 503A) - Certificate of Analysis (CoA) from third-party testing for each batch - Proper cold chain shipping - Clear dosing instructions from a licensed prescriber

Important 2026 note: The FDA shortage designation has been subject to ongoing review. Check current regulatory status when you're researching — availability of compounded semaglutide may change based on whether the shortage remains active.

At Marrow, we work with licensed compounding pharmacies and handle prior authorization support as part of your care. [See pricing →](/pricing)

Option 4: GoodRx and Discount Programs

GoodRx, RxSaver, and similar coupon platforms can reduce brand-name semaglutide prices by 15-30% — not enough to make it fully affordable without insurance, but useful if you're in a coverage gap.

Current GoodRx estimates (verify at time of use): - Ozempic 0.5mg: ~$850-900/month with coupons - Ozempic 1mg: ~$900-950/month with coupons - Wegovy varies significantly by pharmacy

These coupons cannot be combined with insurance — you choose one or the other. For uninsured patients, GoodRx is worth using, but compounded alternatives will typically be more affordable.

Option 5: Patient Assistance Programs

For patients who don't have insurance and meet income requirements, pharmaceutical manufacturers offer Patient Assistance Programs (PAPs) that provide medication at low or no cost.

Novo Nordisk's Patient Assistance Program: Patients with income below 400% of the federal poverty level (~$58,000 for single person, higher for families) may qualify for free or heavily discounted medication. Apply at novonordisk-us.com/pap.

Option 6: Telehealth + Generic-Adjacent Options

Telehealth platforms (like Marrow) can reduce total cost of care by eliminating office visit fees and streamlining the prescription process. Instead of paying for separate doctor visits, labs, and follow-ups, a monthly membership covers ongoing care.

Tirzepatide as an alternative: If semaglutide cost is prohibitive, compounded tirzepatide is sometimes available at competitive pricing with even better clinical outcomes. Ask your provider about this option.

Liraglutide (Saxenda): An older GLP-1 agonist with a solid evidence base — less effective than semaglutide but often available at lower cost. Some patients do very well on it.

The Bottom Line

The most affordable paths to GLP-1 treatment in 2026, in rough order of accessibility:

1. Compounded semaglutide via telehealth — $199-399/month, fastest access, no insurance required
2. Brand-name with manufacturer savings card — $25-99/month, requires commercial insurance
3. Brand-name with full insurance coverage — potentially $0-25/month, requires prior authorization
4. Patient assistance programs — free or near-free, requires income qualification

Don't let cost be the reason you don't start. The metabolic benefits of GLP-1 treatment compound over time — and the long-term cost of untreated obesity and metabolic disease is far higher.

[See Marrow's pricing and what's included →](/pricing)